NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS

FCRN/ANTIGEN-BINDING MOLECULES AND METHODS OF USE

NOVEL ANTI-PAD2 ANTIBODY

ANTI-WT1/HLA ANTIBODIES AND USES THEREOF

ANTIBODIES AGAINST THE POLIOVIRUS RECEPTOR (PVR) AND USES THEREOF

ANTI-CD73 ANTIBODY AND USE THEREOF

BCMA VH-ONLY CARS

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE OR CYSTEINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF

MULTISPECIFIC ANTI-TCR DELTA VARIABLE 1 ANTIBODIES

PH-DEPENDENT ANTI-CD3 ANTIBODIES AND METHODS RELATING THERETO

ANTI-CD112R ANTIBODIES AND USE THEREOF

NOVEL ANTI-L1CAM ANTIBODY

ANTI-FGF23 ANTIBODY OR ANTIBODY FRAGMENT THEREOF

NOVEL ANTIBODIES FOR HIV AND METHODS OF MAKING AND USING SAME

ANTIBODY-DRUG CONJUGATE COMPRISING ANTI-CLAUDIN-18.2 ANTIBODY, AND THERAPEUTIC USE THEREOF FOR CANCER

METHOD FOR PREPARING HER2 NANOBODY AND CONJUGATE, AND USE THEREOF

Antagonistic CD40 Monoclonal Antibodies and Uses Thereof

CHIMERIC ANTIGEN RECEPTORS TARGETING INTERLEUKIN 13 RECEPTOR SUBUNIT ALPHA 2 AND METHODS OF USE THEREOF

ENGINEERED NON-HUMAN ANIMALS

CONSTRUCTION METHOD FOR HUMANIZED ANTIBODY SEQUENCE EVALUATION MODEL AND USE THEREOF

NOVEL PEPTIDES

ANTIBODIES AGAINST FENTANYL AND ANALOGS AND METHODS OF USE THEREOF

HUMAN ANTI-FIBRIN ANTIBODIES AND USES THEREOF

IMMUNOLOGIC AGENT AGAINST CANINE MALIGNANCY

Multi Variable Domain Therapeutic Immunoglobulin

ANTIBODY BINDING TO C-MET AND USE THEREOF

MULTISPECIFIC BINDING PROTEINS THAT BIND DECTIN-1 AND TROP-2 AND METHODS OF USE THEREOF

NANOBODIES FOR CANCER THERAPY

ANTI-PD-1 ANTIBODIES AND METHODS OF USE

ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE

Methods of Treating Kawasaki Disease Using IL-1beta Antibodies

ALBUMIN BINDING PROTEINS AND METHODS OF USE

COMPOSITION COMPRISING ANTI-GLIADIN ANTIBODIES AND METHOD OF USE THEREOF TO DETECT GLIADIN IN A SAMPLE

ANTI-LRRC15 ANTIBODIES AND USES THEREOF

ANTI-TROP2/EGFR ANTIBODIES AND USES THEREOF

ENGINEERED IGA ANTIBODIES AND METHODS OF USE

NOVEL BIOTIN-SPECIFIC MONOCLONAL ANTIBODY AND USE THEREOF

Antigen Binding Proteins

ANTI-SLC3A2-APIS ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF

ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

TREATMENT OF AIHA WITH BAFF OR BAFF RECEPTOR INHIBITORY ANTIBODIES

TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRvIII CHIMERIC ANTIGEN RECEPTOR

CD161 BINDING PROTEINS AND RELATED METHODS

HUMANIZED ANTIBODIES TO HUMAN INTEGRIN AVB8

ANTI-HLA-DQ2.5 ANTIBODY

TRISPECIFIC COMPOSITIONS COMPRISING IL-2, VEGF BINDING DOMAINS, AND PD-1 BINDING DOMAINS

ANTI-CLDN6 ANTIBODIES AND USE THEREOF

ANTIBODIES TARGETING TIGIT AND USES THEREOF

IL31-BINDING POLYPEPTIDES AND USES THEREOF

PRECISION ACTIVATED POLYPEPTIDES

TSLP INHIBITORS AND METHODS OF USE THEREOF

PROTEINS SPECIFIC FOR BAFF AND B7RP1 AND USES THEREOF

FULLY HUMAN MONOCLONAL ANTIBODIES AGAINST HUMAN HER-2

COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARGETING PSMA AND EFFECTOR CELL ANTIGENS

GLYPICAN 3 ANTIBODY AND RELATED METHODS

CAR FOR USE IN THE TREATMENT OF HVG DISEASE

PD-1-BINDING MOLECULES AND METHODS OF USE THEREOF

BISPECIFIC ANTIBODIES THAT BIND PD-L1 AND CD28

ANTI-CD3 ANTIBODIES, BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND CD3 AND CD20, AND USES THEREOF

ANTIBODY CONSTRUCTS FOR DLL3 AND CD3

ANTIBODIES TARGETING CD47 AND USES THEREOF

POLYPEPTIDE CONSTRUCTS SELECTIVELY BINDING TO CLDN6 AND CD3

COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34

Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using Same

SARS-CoV-2 OMICRON BINDING PROTEINS AND METHODS OF USE THEREOF

MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF

CD138/SYNDECAN1 ANTIBODIES AND METHODS OF USE THEREOF

ANTIGEN RECOGNIZING RECEPTORS TARGETING L1CAM AND USES THEREOF

HUMANIZED ANTI-CD40 ANTIBODIES AND USES THEREOF

COMPOSITIONS OF LANCL1 ANTIBODIES AND METHODS OF USE THEREOF FOR TREATING LIVER CANCER

ANTI-LEWIS Y ANTIBODY AND PRO-ANTIBODY THEREOF

ANTI-MET ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND MET, AND METHODS OF USE THEREOF

BINDING MOLECULES SPECIFIC FOR FCGAMMA RIIA AND USES THEREOF

ANTIBODIES BINDING B7-H3 AND USES THEREOF

CANINIZED ANTIBODIES AGAINST CANINE CTLA-4

ANTI-CTLA4 ANTIBODIES AND METHODS OF USE THEREOF

Anti-CTLA-4 Binding Proteins and Methods of Use Thereof

ANTI-CD3 ANTIBODY AND USE THEREOF

SUBCUTANEOUS ADMINISTRATION OF ANTIBODIES FOR THE TREATMENT OF DISEASE

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

CD3-TARGETING ANTIBODY AND USE THEREOF

NOVEL ANTI-LILRB4 ANTIBODIES AND DERIVATIVE PRODUCTS

Antibodies Binding to ILT4

VHH POLYPEPTIDES THAT BIND TO MESOTHELIN, COMPOSITIONS AND METHODS OF USE THEREOF

METHODS OF TREATING CACHEXIA

Methods of Using IL-1beta Compounds

COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34

MOLECULES THAT BIND TO MUTANT CALRETICULIN AND USES THEREOF

HUMAN C6 BINDING MOLECULES FOR TREATING DISEASES

Herpes Zoster Treatment

RELAXIN ANALOGS AND METHODS OF USING THE SAME

FUSION PROTEIN COMPRISING FOLLICLE STIMULATING HORMONE AND ANTIGEN-BINDING FRAGMENT TO SERUM ALBUMIN AND COMPOSITIONS AND USES THEREOF

FULLY HUMAN MONOCLONAL ANTIBODIES AGAINST HUMAN HER-2 AND METHODS FOR USING THE SAME

ANTl-5T4 ANTIGEN BINDING DOMAINS, ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF

CLEC9A BINDING AGENTS

DIRECTED IN VIVO AFFINITY MATURATION OF ANTIBODIES

NOVEL ANTI-PAD4 ANTIBODY

MONOCLONAL ANTIBODY FOR SPECIFICALLY RECOGNIZING GLYPICAN-3, AND APPLICATION THEREOF

VHH ANTIBODIES AND USES THEREOF

ANTIBODIES AND FUSION PROTEINS THAT BIND TO CCR8 AND USES THEREOF

TMEM219 ANTIBODIES AND THERAPEUTIC USES THEREOF

Anti-Urokinase-Type Plasminogen Activator Receptor Antibodies and Methods of Use

NOVEL ANTI-CD3EPSILON ANTIBODIES

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

AGONISTIC ANTIBODIES THAT BIND HUMAN CD40 AND USES THEREOF

DEVELOPMENT AND USE OF NOVEL MULTISPECIFIC TUMOR INHIBITOR

ANTI-TRPV6 MONOCLONAL ANTIBODY AND APPLICATION THEREOF

MONOCLONAL ANTIBODIES TO GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15)

TRISPECIFIC ANTIBODIES TARGETING PD-1, CTLA-4 AND VEGF AND USE THEREOF

Antibodies to Botulinum Neurotoxins

COLLAGEN-LOCALIZED IMMUNOMODULATORY MOLECULES AND METHODS THEREOF

COMPOSITIONS AND METHODS FOR MAKING ANTIBODY CONJUGATES

CDH17-BINDING ANTIBODIES AND METHODS OF USE THEREOF

INTERLEUKIN 15 VARIANTS

CHEMICALLY CONTROLLED MONOCLONAL ANTIBODY TARGET ENGAGEMENT

ANTI-HER2 ANTIBODIES AND METHODS OF USE THEREOF

BISPECIFIC ANTIBODIES AGAINST CEACAM5 AND CD3

MESOTHELIN-TARGETED CD40 AGONISTIC MULTISPECIFIC ANTIBODY CONSTRUCTS FOR THE TREATMENT OF SOLID TUMORS

TRISPECIFIC PROTEINS AND METHODS OF USE

C-C CHEMOKINE RECEPTOR TYPE 8 (CCR8) ANTAGONIST ANTIBODIES

PD-1 BNDING PROTEINS, VEGF AND PD-1 BISPECIFIC BINDING PROTEINS, COMPOSITIONS, AND METHODS OF USE

MONOVALENT CD47 BINDING PROTEINS

ANTI-PILRA ANTIBODIES, USES THEREOF, AND RELATED METHODS AND REAGENTS

ZIP12 ANTIBODY

NEUTRALIZING ANTIBODIES TO HUMAN ENDOTHELIN

ANTIBODIES THAT BIND OX40L AND ANTIBODIES THAT BIND TSLP IN COMBINATION WITH HYALURONIDASE OR A VARIANT THEREOF

RECOMBINANT BISPECIFIC ANTIBODIES TARGETING TSLP AND IL4R

COMPOSITIONS AND METHODS FOR GROWTH FACTOR MODULATION

MULTI-SPECIFIC ANTIGEN BINDING PROTEINS WHICH BIND HUMAN FIBRIN OR FIBRINOGEN YC DOMAIN AND VASCULAR ENDOTHELIAL GROWTH FACTOR AND METHODS OF USE

SARS-COV-2 ANTIBODIES AND METHODS OF USING THE SAME

Non-Human Animals Expressing pH-Sensitive Immunoglobulin Sequences

CLAUDIN18 ANTIBODIES AND METHODS OF TREATING CANCER

MULTISPECIFIC ANTIGEN-BINDING MOLECULES HAVING BLOOD COAGULATION FACTOR VIII (FVIII) COFACTOR FUNCTION-SUBSTITUTING ACTIVITY AND PHARMACEUTICAL FORMULATIONS CONTAINING SUCH A MOLECULE AS AN ACTIVE INGREDIENT

HUMAN CD163 ANTIBODIES AND USES THEREOF

ANTI-OPG ANTIBODIES

NANOBODIES THAT BIND TO GPRC5D AND USES THEREOF

TIE2-BINDING AGENTS AND METHODS OF USE

Methods and Compositions for Modulating Beta Chain Mediated Immunity

BISPECIFIC, MODULATABLE ANTIBODY OR ANTIGEN BINDING FRAGMENTS THEREOF

ANTI-ALPHABETATCR ANTIBODY

FULLY HUMAN ANTIBODY TARGETING CD19 AND APPLICATION THEREOF

ANTI-UNC5C ANTIBODIES

ANTIBODIES THAT SPECIFICALLY BIND CLDN6 OR CD3 AND BISPECIFIC ANTIBODIES THAT SPECIFICALLY BIND CLDN6 AND CD3

HIGH-AFFINITY TIGIT ANTIBODY AND USE THEREOF

SARS-COV2 ANTIBODIES AND METHODS OF USE THEREOF

CD8b-BINDING POLYPEPTIDES

COMBINATION OF TRISPECIFIC ANTIBODY TARGETING BCMA, GPRC5D AND CD3, AND AN ANTI-CD38 ANTIBODY FOR THE TREATMENT OF MULTIPLE MYELOMA

COMBINATION THERAPIES COMPRISING T-CELL REDIRECTING THERAPIES AND AGONISTIC ANTI-IL-2R ANTIBODIES OR FRAGMENTS THEREOF

NEUTRALIZING ANTI-TL1A MONOCLONAL ANTIBODIES

TACI ANTIBODY AND USE THEREOF

ANTI-HUMAN INTERLEUKIN 36 RECEPTOR MONOCLONAL ANTIBODY AND USE THEREOF

IL-4R AND TSLP INHIBITORS AND METHODS OF USE THEREOF

ANTIBODIES AND FUSION PROTEINS THAT BIND TO CCR8 AND USES THEREOF

IMMUNOTOXIN-BASED TARGETED THERAPY FOR CANCER

ANTIBODIES BINDING TO HLA-A2/MAGE-A4

TREATMENT AND PREVENTION OF CANCER USING VISTA ANTIGEN-BINDING MOLECULES

MONOCLONAL ANTIBODIES AGAINST HUMAN PROGRAMMED CELL DEATH PROTEIN 1 (PD-1)

FUSIONS WITH CD8 ANTIGEN BINDING MOLECULES FOR TREATING CHRONIC VIRAL INFECTION

COMPOSITION FOR PROPHYLAXIS OR TREATMENT OF IL-8 RELATED DISEASES

ANTI-TMPRSS6 ANTIBODIES AND USES THEREOF

ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOF

MULTIVALENT FZD4, WNT CO-RECEPTOR, AND VEGF BINDING MOLECULES AND USES THEREOF

ENGINEERED IgG MOLECULES AND METHODS OF USE THEREOF

B7H3/PDL1 BISPECIFIC ANTIBODY, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AND USE THEREOF

FC VARIANTS

TREATMENT OF SOLID ORGAN TRANSPLANT SUBJECTS WITH CD28/OX40 BISPECIFIC ANTIBODIES

TREM2 ANTIBODIES AND USES THEREOF

MULTIVALENT FZD4, WNT CO-RECEPTOR, AND VEGF RECEPTOR MOLECULES AND USES THEREOF

ANTI-IL31 ANTIBODIES FOR VETERINARY USE

ISOFORM-SELECTIVE ANTI-TGF-BETA ANTIBODIES AND METHODS OF USE

ANTI-C1S ANTIBODIES AND METHODS OF USE THEREOF

MONOCLONAL ANTIBODIES TO ARABINOMANNAN (AM), GROEL2, AND LPRG AND METHODS OF USE

COMPOSITIONS AND METHODS FOR USING BISPECIFIC ANTIBODIES TO BIND COMPLEMENT AND A TARGET ANTIGEN

ANTIBODIES AGAINST METAPNEUMOVIRUS FUSION (F) PROTEIN AND USES THEREOF

ANTI-CCR8 ANTIBODIES AND USES THEREOF

MONOCLONAL ANTIBODY INHIBITOR OF FACTOR XIIA

CD163 BINDING PROTEIN

AGONISTIC TNF RECEPTOR BINDING AGENTS

ANTI-FGFR2 ANTIBODIES IN COMBINATION WITH CHEMOTHERAPY AGENTS IN CANCER TREATMENT

ANTI-B7H3 ANTIBODIES AND METHODS OF USE

MULTISPECIFIC BINDING CONSTRUCTS AGAINST CHECKPOINT MOLECULES AND USES THEREOF

METHODS FOR TREATING CANCER USING ANTI-CTLA4 ANTIBODIES

Antibodies Comprising Chimeric Constant Domains

CD3 BINDING ANTIBODIES

ANTI-GPRC5D ANTIBODY AND USE THEREOF

SLIT2 RELATED COMPOSITIONS AND METHODS

ANTI-PD-1 ANTIBODY-ATTENUATED IL-2 IMMUNOCONJUGATE FORMULATIONS

FORMULATIONS AND DOSAGE AMOUNTS FOR ADMINISTERING AN ANTI-DPP3 ANTIBODY OR FRAGMENT THEREOF TO HUMANS

TAU PHOSPHO (THR217) BINDING ANTIBODIES AND ANTIGEN BINDING FRAGMENTS THEREOF

TREATMENT OF CANCER USING CHIMERIC ANTIGEN RECEPTOR

GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS FOR PRODUCING HEAVY-CHAIN ANTIBODIES

MULTISPECIFIC CONSTRUCTS AND USES THEREOF

MULTI-SPECIFIC ANTIBODY BINDING TO BCMA, GPRC5D AND CD3, AND USE THEREOF

METHODS OF TREATING CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING ANTI-FCRN ANTIBODIES

ANTI-PAR2 ANTIBODIES AND USES THEREOF

METHODS AND COMPOSITIONS FOR INCREASING IDURONATE 2-SULFATASE ACTIVITY IN THE CNS

Anti-Abeta Antibodies

ANTI-SEMA3A ANTIBODIES AND THEIR USES FOR TREATING A THROMBOTIC DISEASE OF THE RETINA

SARS-COV2 ANTIBODIES AND USES THEREOF

HEPATITIS B ANTIBODIES

BISPECIFIC FUSION PROTEIN TARGETING TNF-a AND IL-17A, AND USE THEREOF

MYCOBACTERIUM TUBERCULOSIS PROTEINS IN DIAGNOSTIC ASSAYS AND DEVICES FOR TUBERCULOSIS DETECTION AND DIAGNOSIS

Monobody and NK Cells

MICE THAT MAKE VL BINDING PROTEINS

BISPECIFIC HER2 AND CD3 BINDING MOLECULES

ANTIBODIES BINDING TO CEACAM5

MULTI-DOMAIN BINDING MOLECULES

FORMULATIONS FOR ANTI-INSULIN RECEPTOR ANTIBODY AND USES THEREOF

CD25 SINGLE-DOMAIN ANTIBODY, HUMANIZED ANTIBODY AND PREPARATION METHOD THEREOF

KLRB1 BINDING AGENTS AND METHODS OF USE THEREOF

EQUINE ANTIBODY MUTANTS

BISPECIFIC CD16A BINDERS

ENHANCED IMMUNE CHECKPOINT BLOCKADES FORMULATION FOR IMAGE GUIDED LOCAL IMMUNOTHERAPY

ANTI-PD-1 ANTIBODIES

PD-1 AGONIST ANTIBODIES AND METHODS OF TREATING AUTOIMMUNE DISEASES WITH A PD-1 AGONIST ANTIBODY

ANTI-ALPHA BETA TCR BINDING POLYPEPTIDES WITH REDUCED FRAGMENTATION

TIGIT ANTIBODIES, ENCODING NUCLEIC ACIDS AND METHODS OF USING SAID ANTIBODIES IN VIVO

ANTI-TIGIT/RHIL-21 BIFUNCTIONAL FUSION PROTEIN AND USE THEREOF

PILRA Antibodies and Methods of Use Thereof

ANTIBODIES TARGETING C-KIT AND/OR SIGLEC AND USES THEREOF

ANTI-SIGLEC-15 ANTIBODY AND USE THEREOF

MODULATORS

IL-17 BINDING PROTEINS, COMPOSITIONS, AND METHODS OF USE THEREOF

AFFIBODY-BASED DUAL AFFINITY FUSION PROTEINS AND USES THEREOF

MONOVALENT ANTI-PROPERDIN ANTIBODIES AND ANTIBODY FRAGMENTS

ANTI-DENV3 ANTIBODIES

SINGLE DOMAIN ANTIBODIES TARGETING HPV E6/E7 ONCOGENIC PEPTIDE/MHC COMPLEXES

STABILIZED IMMUNOGLOBULIN DOMAINS

ANTI-SARS-COV-2-SPIKE GLYCOPROTEIN ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS

CD8 BINDING AGENTS

BISPECIFIC HER2 AND CD3 BINDING MOLECULES

METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION

COMMERCIAL-SCALE RECOMBINANT PROTEIN PRODUCTION IN RAT HYBRIDOMA CELLS

Antibody Targeting BCMA, Bispecific Antibody, And Use Thereof

ANTIBODIES AGAINST TL1A AND USES THEREOF

MUTANT PROMOTING HOMOLOGOUS PAIRING OF HEAVY AND LIGHT CHAINS OF MULTISPECIFIC ANTIBODY

MULTI-SPECIFIC ANTIBODIES AND METHODS OF USE

ANTI-UNC5C ANTIBODIES

NOVEL ANTI-NECTIN-4 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

ANTI-TIRC7 ANTIGEN BINDING PROTEINS

ANTI-PAR-2 ANTIBODIES AND METHODS OF USE THEREOF

IL13 AND IL31 BISPECIFIC POLYPEPTIDES AND USES THEREOF

METHOD OF ASSESSING ANTI-PRURITIC ACTIVITY OF A CANINE ANTI-IL-31 ANTIBODY CANDIDATE

BISPECIFIC ANTIBODY AND USE THEREOF

ANTIBODY AND USE THEREOF

COMPOSITIONS AND METHODS FOR LINEAR AND CONFORMATIONAL SITE-SPECIFIC ANTIBODIES AND METHODS OF MAKING THE SAME

ALPHAVIRUS ANTIGEN BINDING ANTIBODIES AND USES THEREOF

Human Immunodeficiency Virus Neutralizing Antibodies and Methods of Use Thereof

Compositions and Methods for the Prevention and Treatment of Orthopoxvirus Infections

FUSION PROTEIN COMPRISING ANTI-CD73 ANTIBODY AND IL-2, AND USE THEREOF

Method for Predicting and Modulating Glycation of a Protein

METHODS FOR GENERATING GAMMA DELTA T-CELLS AND RELATED COMPOSITIONS

COMPOSITIONS TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) AND METHODS FOR MAKING AND USING THE SAME

BISPECIFIC ANTIBODY AND USE THEREOF

TL1A BINDING PROTEINS AND METHODS OF USE

TARGETING EPHA3 AND USES THEREOF

BISPECIFIC ANTIBODIES AND CONSTRUCTS FOR LYSOSOMAL TARGETING DEGRADATION AND METHODS OF USE THEREOF

ANTI-KIT ANTIBODY FORMULATIONS AND METHODS

BISPECIFIC ANTIBODY AND USE THEREOF

SILENT ANTI-CD8 ANTIBODIES AND FUSION PROTEINS

ANTI-L1-CAM ANTIBODIES AND THEIR USES FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

KIDNEY TARGETING ANTIBODIES

SYNTHETIC EXTRACELLULAR INTERLEUKIN 23 BIOSENSORS

ANTI-IL-27 ANTIBODIES AND USES THEREOF

VEGF ANTAGONISTS AND METHODS OF USE THEREOF

ALBUMIN BINDING PROTEINS AND METHODS OF USE

METHODS OF USING ANTI-PSGL-1 ANTIBODIES IN COMBINATION WITH JAK INHIBITORS TO TREAT T-CELL MEDIATED INFLAMMATORY DISEASES OR CANCERS

CONDITIONALLY ACTIVE ANTI-EPCAM ANTIBODIES, ANTIBODY FRAGMENTS, THEIR IMMUNOCONJUGATES AND USES THEREOF

METHOD FOR GENERATING HIGH AFFINITY ANTIBODIES

TREM2 BINDS TO SPECIFICALLY STRUCTURED HEPARAN SULFATE

TETRAVALENT MULTISPECIFIC ANTIBODIES

Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders

Anti-MuSK Agonistic Antibodies

PROTEASE-CLEAVABLE MOIETIES AND METHODS OF USE THEREOF

ANTI-PD-L1 MULTIPARATOPIC ANTIBODY CONSTRUCTS AND USES THEREOF

MULTISPECIFIC ANTIBODY WITH COMBINATION THERAPY FOR IMMUNO-ONCOLOGY

TUMOR ACTIVATED ANTIBODIES TARGETING CD3 AND USES THEREOF

OPTIMIZED ANTIBODIES TARGETING CD3 AND USES THEREOF

RABBIT MONOCLONAL ANTIBODIES TARGETING MULTIPLE MYELOMA CELL SURFACE ANTIGENS

ANTIBODY-BASED MOLECULE OR COMPLEX, EXPRESSION SYSTEM AND PHARMACEUTICAL COMPOSITION THEREOF, AND METHODS THEREOF

FOLLISTATIN-FC FUSION PROTEINS

SINGLE-CHAIN PRASINEZUMAB ANTIBODY-TRANSFERRIN FUSION PROTEIN FOR ENHANCED EFFICACY AND INDICATIONS

NOVEL PI3K AND/OR PIKK INHIBITORS, ANTIBODY-DRUG CONJUGATES COMPRISING THE SAME AND USES THEREOF

ANTI-MESOTHELIN ANTIBODY CONJUGATES AND METHODS OF USE THEREOF

ANTI-CD19 ANTIBODIES AND CAR-T STRUCTURES

CYTOKINE FUSION PROTEIN CAPABLE OF CONDITIONAL RELEASE AND ACTIVATION, AND PREPARATION AND USE THEREOF

Anti-TDP-43 Binding Molecules

CASSETTES OF ANTI-COMPLEMENT COMPONENT 3 ANTIBODY, VECTORIZATION AND THERAPUTIC APPLICATION

ANTIBODY REPURPOSING

MULTISPECIFIC MOLECULES FOR CLEARANCE OF IMMUNOGLOBULINS IN THE TREATMENT OF AUTOANTIBODY-INDUCED DISEASES

COMPOSITION

ANTI-CD24 ANTIBODIES AND USES THEREOF

Modified IgG1 Fc Domains and Anti-CD40 Domain Antibody Fusions Therewith

ANTIBODIES TO CD70

ANTI C-MET ANTIBODIES

CYSTEINE ENGINEERED ANTIBODY CONSTRUCTS, CONJUGATES AND METHODS OF USE

ANTI-TREM2 ANTIBODIES AND RELATED METHODS

BTN2A1 BINDING PEPTIDE

ANTI-CORTICOTROPIN-RELEASING HORMONE ANTIBODIES AND POLYCYSTIC OVARY SYNDROME

METHODS OF TREATING SARCOIDOSIS WITH A TNF-A ANTIBODY AND ASSOCIATED COMPOSITIONS AND METHODS